Project support for a phase 3 clinical trial to demonstrate the efficacy of a shortened treatment regimen for children with TB

Project support to test and treat approximately 11,000 people suffering from visceral leishmaniasis per year

Project support for the Accelerate Resilient, Innovative, and Sustainable Elimination of NTDs-2 (ARISE-2) program, aiming to accelerate the elimination of onchocerciasis, lymphatic filariasis, schistosomiasis, soil-transmitted helminths, and trachoma

Project support to strengthen measles outbreak preparedness, response, and recovery capacity throughout Africa